{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:58:36Z","timestamp":1788238716831,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ijcard.2017.02.018","type":"journal-article","created":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T09:31:51Z","timestamp":1486546311000},"page":"344-350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Combined baseline and one-month changes in big endothelin-1 and brain natriuretic peptide plasma concentrations predict clinical outcomes in patients with left ventricular dysfunction after acute myocardial infarction: Insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study"],"prefix":"10.1016","volume":"241","author":[{"given":"A","family":"Olivier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Girerd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JB","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JM","family":"Ketelslegers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Fay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Bramlage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Pitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Zannad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Rossignol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2017.02.018_bb0005","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/eurheartj\/ehr254","volume":"33","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0010","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1161\/01.CIR.0000054164.99881.00","article-title":"Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT)","volume":"107","author":"Anand","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.02.018_bb0015","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000080338","article-title":"Profibrotic effects of endothelin-1 via the ETA receptor in cultured human cardiac fibroblasts","volume":"14","author":"Hafizi","year":"2004","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0020","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/01.CIR.89.4.1580","article-title":"Endothelin in human congestive heart failure","volume":"89","author":"Wei","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.02.018_bb0025","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/01.CIR.85.4.1374","article-title":"Plasma endothelin in chronic heart failure","volume":"85","author":"McMurray","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.02.018_bb0030","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.cardfail.2004.04.001","article-title":"Superiority of big endothelin-1 and endothelin-1 over natriuretic peptides in predicting survival in severe congestive heart failure: a 7-year follow-up study","volume":"10","author":"Van Beneden","year":"2004","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0035","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cardfail.2006.02.013","article-title":"The prognostic value of big endothelin-1 in >2.300 patients with heart failure enrolled in the Valsartan Heart Failure Trial (Val-HeFT)","volume":"12","author":"Masson","year":"2006","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0040","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.ahj.2007.06.016","article-title":"C-terminal pro-endothelin-1 offers additional prognostic information in patients after acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) Study","volume":"154","author":"Khan","year":"2007","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0045","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1161\/CIRCULATIONAHA.111.063842","article-title":"Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease","volume":"125","author":"Sabatine","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.02.018_bb0050","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0008-6363(00)00264-9","article-title":"Pulmonary endothelinergic system in experimental congestive heart failure","volume":"49","author":"Lepailleur-Enouf","year":"2001","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0055","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/01.CIR.102.10.1132","article-title":"Pulmonary release and coronary and peripheral consumption of big endothelin and endothelin-1 in severe heart failure: acute effects of vasodilator therapy","volume":"102","author":"Stangl","year":"2000","journal-title":"Circulation"},{"issue":"Suppl. 3","key":"10.1016\/j.ijcard.2017.02.018_bb0060","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1097\/00005344-199506263-00011","article-title":"Measurement of C-terminal fragment of big endothelin-1: a novel method for assessing the generation of endothelin-1 in humans","volume":"26","author":"Plumpton","year":"1995","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0065","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1373\/clinchem.2006.069575","article-title":"Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data","volume":"52","author":"Masson","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0070","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1001\/archinte.166.3.315","article-title":"Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department","volume":"166","author":"Januzzi","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0075","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ejheart.2008.07.014","article-title":"State of the art: using natriuretic peptide levels in clinical practice","volume":"10","author":"Maisel","year":"2008","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0080","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0085","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1161\/CIR.0b013e31829e8807","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.02.018_bb0090","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1161\/01.CIR.89.5.1934","article-title":"N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction","volume":"89","author":"Hall","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.02.018_bb0095","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.cardfail.2005.05.004","article-title":"Plasma natriuretic peptides up to 2years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy","volume":"11","author":"Squire","year":"2005","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0100","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.jacc.2008.01.041","article-title":"Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study","volume":"51","author":"Khan","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0105","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.jacc.2011.03.072","article-title":"Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction","volume":"58","author":"Januzzi","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0110","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/CIRCULATIONAHA.112.120493","article-title":"Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are not useful in heart failure management: the art of medicine remains long","volume":"127","author":"Desai","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.02.018_bb0115","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/eurheartj\/ehu134","article-title":"BNP-guided therapy for chronic heart failure: anything more than just an attractive concept?","volume":"35","author":"Cowie","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0120","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/eurheartj\/ehu090","article-title":"Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis","volume":"35","author":"Troughton","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0125","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.ahj.2010.02.019","article-title":"Endothelin-1 release in acute myocardial infarction as a predictor of long-term prognosis and no-reflow assessed by contrast-enhanced magnetic resonance imaging","volume":"159","author":"Eitel","year":"2010","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/CRD.0b013e318283f65a","article-title":"Endothelin in coronary artery disease and myocardial infarction","volume":"21","author":"Kolettis","year":"2013","journal-title":"Cardiol. Rev."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0135","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1161\/01.CIR.89.4.1573","article-title":"Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction","volume":"89","author":"Omland","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.02.018_bb0140","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0002-8703(93)90155-3","article-title":"Plasma endothelin-1 in acute myocardial infarction with heart failure","volume":"125","author":"Tomoda","year":"1993","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0145","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0150","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1161\/CIRCULATIONAHA.108.809194","volume":"119","author":"Iraqi","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.02.018_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014506","article-title":"Identification of chronic heart failure patients with a high 12-month mortality risk using biomarkers including plasma C-terminal pro-endothelin-1","volume":"6","author":"Jankowska","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2017.02.018_bb0160","doi-asserted-by":"crossref","first-page":"331","DOI":"10.5507\/bp.2012.110","article-title":"Can markers of collagen turnover or other biomarkers contribute to the diagnostics of heart failure with normal left ventricular ejection fraction?","volume":"157","author":"Meluzin","year":"2013","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0165","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jacc.2011.11.082","article-title":"Endothelial dysfunction, arterial stiffness, and heart failure","volume":"60","author":"Marti","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0170","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1161\/01.CIR.101.23.2764","article-title":"Hemodynamic stresses induce endothelial dysfunction and remodeling of pulmonary artery in experimental compensated heart failure","volume":"101","author":"Ben Driss","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.02.018_bb0175","doi-asserted-by":"crossref","first-page":"C389","DOI":"10.1152\/ajpcell.1992.263.2.C389","article-title":"Physiological fluid shear stress causes downregulation of endothelin-1 mRNA in bovine aortic endothelium","volume":"263","author":"Malek","year":"1992","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0180","article-title":"Ventricular tachyarrhythmias during acute myocardial infarction: the role of endothelin-1","author":"Kolettis","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0185","article-title":"Endothelin B-receptors and sympathetic activation: impact on ventricular arrhythmogenesis during acute myocardial infarction","author":"Kolettis","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0190","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/clinchem\/43.1.64","article-title":"Sandwich-type enzyme immunoassay for big endothelin-I in plasma: concentrations in healthy human subjects unaffected by sex or posture","volume":"43","author":"Aubin","year":"1997","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0195","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.atherosclerosis.2014.12.061","article-title":"Plasma endothelin-1 and cardiovascular risk among young and healthy adults","volume":"239","author":"Bossard","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2017.02.018_bb0200","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1054\/jcaf.2000.8833","article-title":"Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure","volume":"6","author":"Selvais","year":"2000","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0205","first-page":"H890","article-title":"Myocardial recruitment during ANF mRNA increase with volume overload in the rat","volume":"251","author":"Lattion","year":"1986","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0210","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0002-8703(98)70041-9","article-title":"Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction","volume":"135","author":"Maeda","year":"1998","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0215","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0002-9149(99)80748-6","article-title":"Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction. SOLVD Investigators","volume":"75","author":"Benedict","year":"1995","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0220","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ejheart.2007.07.010","article-title":"Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a beta-blocker: results from the Carvedilol Or Metoprolol European Trial (COMET) trial","volume":"9","author":"Olsson","year":"2007","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0225","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/01.CIR.0000036747.68104.AC","article-title":"Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT)","volume":"106","author":"Latini","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.02.018_bb0230","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jacc.2005.04.038","article-title":"Eplerenone reduces mortality 30days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure","volume":"46","author":"Pitt","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0235","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1093\/eurheartj\/ehu164","article-title":"Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study","volume":"35","author":"Montalescot","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0240","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.jacc.2011.04.049","volume":"58","author":"Rossignol","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0245","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0735-1097(01)01210-4","article-title":"Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?","volume":"37","author":"Spieker","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0250","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1161\/01.CIR.96.6.1976","article-title":"Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling","volume":"96","author":"Mulder","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.02.018_bb0255","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cardfail.2004.05.006","article-title":"Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study","volume":"11","author":"Packer","year":"2005","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0260","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1161\/01.CIR.98.21.2262","article-title":"Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure","volume":"98","author":"Sutsch","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2017.02.018_bb0265","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10741-009-9152-z","article-title":"Potential of endothelin-1 and vasopressin antagonists for the treatment of congestive heart failure","volume":"15","author":"Rehsia","year":"2010","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.ijcard.2017.02.018_bb0270","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jchf.2013.12.002","article-title":"Randomized, double-blind, placebo-controlled study of sitaxsentan to improve impaired exercise tolerance in patients with heart failure and a preserved ejection fraction","volume":"2","author":"Zile","year":"2014","journal-title":"JACC Heart Fail."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316321155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316321155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T23:19:38Z","timestamp":1601594378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316321155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":54,"alternative-id":["S0167527316321155"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.02.018","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727376798.793529375","asserted-by":"object"}]},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined baseline and one-month changes in big endothelin-1 and brain natriuretic peptide plasma concentrations predict clinical outcomes in patients with left ventricular dysfunction after acute myocardial infarction: Insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}